RLYB RLYB
Company Profile ↓Company Overview
RLYB (RLYB) is a publicly traded company listed on with a market capitalization of $85.27M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.30.
Recent Developments
- Dec 2025 Revenue of $858.00K (+34.9% YoY); net profit $-8.98M.
- Trailing 12 Months Year-on-year growth — revenue +34.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | 34.91% |
Stock Price Performance
| 1 Year: | +281.38% |
| 6 Months: | +222.28% |
| 3 Months: | +13.03% |
| 1 Month: | +3.00% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)53.52 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 299.00K | 299.00K | - | 212.00K | 212.00K | 212.00K | 222.00K | 212.00K |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.88M | 10.27M | 7.14M | 6.63M | 8.95M |
| Operating Income | -4.66M | -6.71M | -12.82M | -10.53M | -9.98M | -14.32M | -17.61M | -18.86M | -18.37M | -20.08M | -19.36M | -19.79M | -17.04M | -12.07M | - | -9.67M | -10.06M | -6.92M | -6.41M | -8.73M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -9.64M | -10.03M | -6.89M | -6.41M | -8.73M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -9.44M | -9.42M | 16.02M | -5.85M | -8.28M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income | -4.89M | -7.16M | -13.28M | -11.13M | -10.20M | -14.50M | -17.58M | -18.37M | -17.32M | -18.63M | -18.37M | -19.03M | -16.24M | -11.47M | - | -9.44M | -9.70M | 16.02M | -5.85M | -8.28M |
| Diluted EPS | - | - | - | -0.49 | -0.37 | -0.48 | -0.57 | -0.60 | -0.43 | -0.46 | -0.45 | -0.47 | -0.37 | -0.26 | -2.00 | -1.68 | -1.76 | 2.88 | - | -1.46 |
| R&D Expense | 3.09M | 5.13M | 9.04M | 6.82M | 4.96M | 7.65M | 10.14M | 12.11M | 11.20M | 13.13M | 13.29M | 12.94M | 12.95M | 8.24M | - | 5.72M | 6.07M | 4.14M | - | 2.87M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 0 | 0 | 636.00K | 858.00K |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | - | - | 67.88M | 78.93M | 61.13M | 33.92M |
| Operating Income | -25.30M | - | -67.88M | -78.93M | -60.50M | -33.06M |
| EBITDA | - | - | -67.72M | -78.78M | -60.37M | -32.97M |
| Interest Expense | - | 10.00K | 0 | - | - | - |
| Pretax Income | - | - | -66.65M | -74.56M | -57.77M | -8.98M |
| Tax Provision | - | 0 | - | - | - | - |
| Net Income | -26.45M | - | -66.65M | -74.56M | -57.77M | -8.98M |
| Diluted EPS | - | - | -16.72 | -14.72 | -10.64 | -1.59 |
| R&D Expense | 17.63M | 26.91M | 40.69M | 53.54M | 41.51M | 19.60M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | - | 141.86M | - | 180.44M | 115.62M | 68.11M | 62.26M |
| Current Assets | - | - | - | 179.50M | 114.79M | 67.84M | 61.25M |
| Cash & Equivalents | - | 140.23M | - | 56.96M | 24.49M | 13.90M | 31.37M |
| Inventory | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - |
| Total Liabilities | - | 5.86M | - | 11.12M | 9.44M | 6.45M | 4.30M |
| Current Liabilities | - | 5.84M | - | 10.74M | 9.26M | 6.24M | 4.22M |
| Long Term Debt | - | - | - | - | - | - | - |
| Total Debt | - | - | - | 555.00K | 392.00K | 154.00K | 176.00K |
| Total Equity | 16.86M | 136.00M | - | 169.32M | 106.18M | 61.65M | 57.96M |
| Shares Outstanding | - | - | - | 4.73M | 4.73M | 5.19M | 5.28M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -22.04M | - | -57.28M | -60.27M | -49.28M | -29.81M |
| Investing Cash Flow | -2.07M | - | -112.17M | 27.66M | 33.49M | 47.27M |
| Financing Cash Flow | 144.89M | - | 51.08M | 143.00K | 5.20M | 16.00K |
| Capital Expenditure | -137.00K | -333.00K | -54.00K | -12.00K | - | - |
| Free Cash Flow | -22.18M | - | -57.34M | -60.28M | -49.28M | -29.81M |
| Net Change in Cash | - | - | -118.38M | -32.46M | -10.59M | 17.47M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | -9,511.9% | -3,853.6% |
| Net Margin % | - | - | - | - | -9,084.1% | -1,046.4% |
| ROE % | -19.4% | - | -39.4% | -70.2% | -93.7% | -15.5% |
| ROCE % | -18.6% | - | -40.0% | -74.2% | -97.8% | -57.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for RLYB
Laurion Capital exits Rallybio (RLYB) position, reports 0% beneficial ownership - Stock Titan
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxOcUo4MGJEU0pSRjZvOVZkejhnTndidXFpNTR4cm4wY1ZqdzJqR1BNTWdBV1hZZnFaR3RHZ00zOVIybFo1aUhMQWVVbk4tYzFyOExCazZ4QjFCdjlmUWJOaVVOUlMwQkltVVJjUlpNQ1pCclJqclZYUHFHN3ZYbFR5dTh1UHE2Uzh4RzNrRH…
RLYB Stock Hits 2-Year Highs After Unveiling Merger With Avenzo – How Much Of The New Company Will Rallybio Shareholders Own? - Stocktwits
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxOcGNnTVI4djY2SkhCTHEyNGZpcHVYd1N0YVlRVllqVWVob05leHY0U1hIU3hEeUFoWGJWNklEaThtd3JZZVpGRUo2NEhsOV9yc3BvTXJMcG85Nl9oYnlGWEtHMVE5aTRNWnFjWTVNWGVCTHkzN1FlLUJBOHFVM1k0SEpwbEJGbWhOYkVuaz…
Rallybio Corporation Revenue Breakdown – NASDAQ:RLYB - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE1FTDNPTVlOMGIwdTlUS2V0VjNocFNtTGxVX09RZ0Fpa2Nxc055cEhEbDRWY3NTN1BJQkM0UjRmM3Y5WjJRdm54T0g1ckhVR05DUmY1d0hEUzRGZm94d0JPVWlCX2RlZ3pOMmp5UlhPS3FlU0JqamIw?oc=5" target="_blank">Rallybi…
Rallybio Stock (RLYB) Opinions on Merger Termination Fee and Insider Buys | RLYB Stock News - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxNVTdoekloU291TzhXbUNGbm9tQm9zdFdIVXVtV3pjYlBWOUozOUdUS1RZTWUzbFVndllPSGM3UFUxaUlUd1lMeS15alUxcFVibVdHeW9tOHlYcmt0enJXNVNBMkJBOHJ0bFF2dnJmN1gxWWk5UGhMTXlxeGt5UUhBNFFrdkN5SUxPNnlDY3…
RLYB - Finviz
<a href="https://news.google.com/rss/articles/CBMiRkFVX3lxTE1qN0hTRm1mVDR3NXVjUm84Nk52aUJVd2l4Y28yTUpuOV83dHZ5U3RxU2ozRktkU1hwSnl5Y214MzRFaG5LQ0E?oc=5" target="_blank">RLYB</a> <font color="#6f6f6f">Finviz</font>…
Adar1 Capital Management buys $1.11m of Rallybio (RLYB) stock - Investing.com
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxOZEFJX1UxZkl1RVVzdHZoSWE0cHNfRURMTzFTV2ZJdEgyWHBDZTZRQmg5UERJYVJMdVBmaGRkd08yU1NXTVFnZmdHYjNsV3FkVW9RMHZ3WVUxaWFWWlFoVU9WbVJsbDI1YmdqSDRUcFBhZkI2UFBqSlI0Um9FWnVlazRtSEp2cEdHQTU5RH…
RLYB — Frequently Asked Questions
What is the current share price of RLYB?
As of 2026-08-05 17:25 PDT, RLYB trades at $16.14 on NASDAQ/NYSE. Its 52-week range is $3.98 to $16.91.
What is the market capitalisation of RLYB?
RLYB has a market capitalisation of $85.27M on NASDAQ/NYSE.
What is the P/E ratio of RLYB?
RLYB trades at a trailing price-to-earnings (P/E) ratio of -10.15. Its price-to-book (P/B) ratio is 1.47.
What is the return on equity (ROE) of RLYB?
RLYB has a return on equity (ROE) of -15.49%. Its return on capital employed (ROCE) is -56.97%.
Is RLYB a good stock to buy?
This page provides a data-driven analysis of RLYB, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.